tiprankstipranks
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE
Poland Market
SVE
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
RESEARCH TOOLSreports
Want to see PL:SVE full AI Analyst Report?

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Income Statement

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Income Statement

Last quarter (Q4 2025), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was zł17.51M, a decrease of -40.15% from the same quarter last year. In Q4, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was zł-6.90M. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
zł 42.01Mzł 71.76Mzł 58.61Mzł 50.38Mzł 41.15M
Gross Profit
zł 12.99Mzł 44.25Mzł 35.17Mzł 28.47Mzł 22.67M
Operating Expenses
zł 33.57Mzł 31.82Mzł 26.52Mzł 18.09Mzł 15.47M
Depreciation and Amortization
zł 13.29Mzł 7.51Mzł 6.63Mzł 6.22Mzł 6.54M
EBITDA
zł -7.28Mzł 20.26Mzł 14.89Mzł 15.40Mzł 13.09M
Operating Income
zł -20.58Mzł 12.43Mzł 8.65Mzł 9.84Mzł 7.19M
Other Income/Expenses
zł -3.33Mzł -2.78Mzł -2.08Mzł -1.50Mzł -1.30M
Pretax Income
zł -23.91Mzł 9.64Mzł 6.57Mzł 8.35Mzł 5.89M
Net Income
zł -19.93Mzł 7.55Mzł 4.76Mzł 6.08Mzł 4.25M
Per Share Metrics
Basic EPS
zł -0.27zł 0.11zł 0.07zł 0.09zł 0.07
Diluted EPS
zł -0.27zł 0.11zł 0.07zł 0.09zł 0.07
Weighted Average Shares Outstanding
 72.55M 70.52M 70.26M 65.38M 63.12M
Weighted Average Shares Outstanding (Diluted)
 72.55M 70.52M 70.26M 65.38M 63.12M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Earnings and Revenue History